Atriva Therapeutics, founded in 2015, is a biopharmaceutical company specifically pioneering the development of host-targeting antiviral therapies set up by a team of leading scientists in viral research and seasoned industry experts.

Biotechnology

Atriva Therapeutics

This office likely focuses on preclinical development and medical leadership in the biopharmaceutical sector.

Planegg/Martinsried

Atriva Therapeutics' headquarters in Tübingen, Germany

Stephan Stenglein

Tim Overend

Ulrich Dauer

Stephan Ludwig

Paul Lelieveld

Stephan Pleschka

Frank Hensel

Rudolf Erlemann

The Advisory Team at Atriva Therapeutics provides strategic guidance and expert insights to support the development and advancement of host-targeting antiviral therapies. Comprising esteemed scientists and industry experts, the team advises on scientific, clinical, and regulatory aspects to drive the company's innovation and success.

Advisory Team

The Leadership Team at Atriva Therapeutics is responsible for steering the strategic direction of the company, overseeing drug development programs, and ensuring the efficient operation of research and development initiatives. Comprising experts in chemistry, manufacturing controls, and clinical operations, the team collaborates to drive innovation in host-targeting antiviral therapies while ensuring compliance with regulatory standards and aligning organizational goals with scientific advancements.

Atriva Therapeutics

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

Atriva Therapeutics

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

Related companies